Microbial Genomics as a Guide to Drug Discovery and Structural Elucidation: ECO-02301, a Novel Antifungal Agent, as an Example
Citations Over TimeTop 10% of 2005 papers
Abstract
Analysis of the genome of Streptomyces aizunensis NRRL B-11277 indicated its potential to produce a compound of novel and highly predictable structure. The structure was predicted with sufficient accuracy to allow straightforward detection of the specific metabolite in HPLC profiles of fermentation extracts and hence to guide the isolation. The spectroscopic work was reduced to a confirmation of structure rather than a first principle determination. The compound, ECO-02301 (1), demonstrated potent antifungal activity. This work exemplifies not only the discovery of novel antibiotics from well-characterized organisms but also the utility of genomics as a further tool, complementary to spectroscopy, to enable rapid determination of complex structures.
Related Papers
- → Novel antifungal drugs(1999)91 cited
- → Antifungals and antifungal drug discovery.(2012)5 cited
- Progress on Research of Antifungal Drugs(2006)
- → Antifungal Pharmacokinetics and Pharmacodynamics(2016)1 cited
- Study progress and clinical application on antifungal drugs(2003)